Target intelligence / Profile preview

Toxic heavy metal ions

Molecular classification
Inorganic ion, Environmental toxin, Carcinogen
01

Overview

Toxic heavy metal ions, such as arsenic, cadmium, lead, and mercury, are non-essential elements that can accumulate within the tumor microenvironment (TME) due to environmental exposure or metabolic dysfunction. These ions are recognized as potent carcinogens that promote tumor development and progression by inducing chronic oxidative stress and generating reactive oxygen species (ROS) [1][2]. In the TME, they disrupt genomic stability by causing direct DNA damage and inhibiting essential DNA repair enzymes, such as those involved in nucleotide excision repair [3]. Additionally, heavy metals can alter cellular signaling pathways and epigenetic patterns, contributing to the epithelial-to-mesenchymal transition (EMT) and enhanced metastatic potential [4]. While they are not traditional biological targets like receptors or enzymes, they are the focus of therapeutic interventions using chelating agents, which bind the ions to facilitate their excretion, and emerging nanoparticle-based sequestration strategies [5]. Managing the levels of these metals is critical, as their presence in the TME is associated with increased malignancy and resistance to conventional therapies [6].

Other names
Heavy metalsToxic metalsEnvironmental metallic carcinogensMetallotoxinsToxic heavy metal ions in the tumor microenvironment
02

Mechanism of action

Chelation of metal ions to form stable, water-soluble complexes for renal or fecal excretion; Sequestration via functionalized nanoparticles to prevent biological interaction within the tumor microenvironment.

03

Biological functions

Induction of oxidative stressDNA damageEpigenetic modulationInhibition of DNA repairDisruption of cellular signaling
04

Disease associations

CancerInflammationGenotoxicityImmunosuppressionNeurotoxicity
05

Safety considerations

NephrotoxicityDepletion of essential trace minerals (e.g., zinc, copper)Redistribution of metals to the central nervous systemHypocalcemia
06

Interacting drugs

Dimercaptosuccinic acid

4 more in the full profile.

07

Biomarkers

Blood metal levelsUrinary metal levels8-hydroxy-2'-deoxyguanosine (8-OHdG)Malondialdehyde (MDA)Glutathione levels

Beyond the preview

Go deeper on Toxic heavy metal ions.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Toxic heavy metal ions.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call